Congenital Toxoplasmosis: Systematic Review of Evidence of Efficacy of Treatment in Pregnancy

Overview

Journal BMJ

Specialty General Medicine

Date 1999 Jun 4

PMID 10356003

Citations 29

Authors

M Wallon

C Liou

P Garner

F Peyron

Affiliations

Soon will be listed here.

Abstract

Objective: To summarise the evidence that treating toxoplasmosis in pregnancy reduces the risk of congenital toxoplasma infection and improves infant outcomes.

Design: Systematic review of studies comparing at least two concurrent groups of pregnant women with proved or likely acute toxoplasma infection in which treatments were compared with no treatment and outcomes in the children were reported.

Subjects: Studies were identified from Medline (1966-97), Pascal (1990-7), Embase (1993-7), and Biological abstracts (1993-5) plus contact with experts in the field, including the European Research Network on Congenital Toxoplasmosis.

Main Outcome Measure: Proportion of infected children at 1 year born to infected pregnant women who were or were not treated.

Results: Out of 2591 papers identified, nine met the inclusion criteria. There were no randomised comparisons, and control groups were generally not directly comparable with the treatment groups. Congenital infection was common in treated groups. five studies showed that treatment was effective and four that it was not.

Conclusion: It is unclear whether antenatal treatment in women with presumed toxoplasmosis reduces congenital transmission of Toxoplasma gondii. Screening is expensive, so the effects of treatment and impact of screening programmes need to be evaluated. In countries where screening or treatment is not routine, these technologies should not be introduced outside carefully controlled trials.

Citing Articles

infection in HIV-infected pregnant women: epidemiology and risks of mother-to-child transmission.

Lampejo T Pan Afr Med J. 2022; 42:275.

PMID: 36405653 PMC: 9636734. DOI: 10.11604/pamj.2022.42.275.33160.

What obstetricians should be aware of: serious side effects of antibiotic toxoplasmosis treatment in pregnancy.

Ardabili S, Kohl J, Gul G, Hodel M BMJ Case Rep. 2021; 14(3).

PMID: 33649030 PMC: 7929819. DOI: 10.1136/bcr-2020-240809.

The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.

Binquet C, Lejeune C, Seror V, Peyron F, Bertaux A, Scemama O PLoS One. 2019; 14(9):e0221709.

PMID: 31532766 PMC: 6750576. DOI: 10.1371/journal.pone.0221709.

Distribution of IgM and IgG antibody seropositivity among age groups and gestational periods in pregnant women.

Sadiqui S, Shah S, Almugadam B, Shakeela Q, Ahmad S F1000Res. 2019; 7:1823.

PMID: 31249669 PMC: 6584968. DOI: 10.12688/f1000research.15344.3.

Treatment of Toxoplasmosis and Neosporosis in Farm Ruminants: State of Knowledge and Future Trends.

Sanchez-Sanchez R, Vazquez P, Ferre I, Ortega-Mora L Curr Top Med Chem. 2018; 18(15):1304-1323.

PMID: 30277158 PMC: 6340160. DOI: 10.2174/1568026618666181002113617.

References

GARIN J, Paillard B . [Experimental toxoplasmosis in mice. Comparative activity of clindamycin, midecamycin, josamycin, spiramycin, pyrimethamine-sulfadoxine, and trimethoprim-sulfamethoxazole]. Ann Pediatr (Paris). 1984; 31(10):841-5. View

DESMONTS G, Couvreur J . Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Engl J Med. 1974; 290(20):1110-6. DOI: 10.1056/NEJM197405162902003. View

LAMBOTTE R . [Congenital toxoplasmosis. Evaluation of the benefit of prenatal therapy]. J Gynecol Obstet Biol Reprod (Paris). 1976; 5(2):265-9. View

DESMONTS G, Couvreur J . [Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy]. Ann Pediatr (Paris). 1984; 31(10):805-9. View

Bader T, Macones G, Asch D . Prenatal screening for toxoplasmosis. Obstet Gynecol. 1997; 90(3):457-64. DOI: 10.1016/s0029-7844(97)00291-3. View

Hohlfeld P, Daffos F, Costa J, Thulliez P, Forestier F, Vidaud M . Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 1994; 331(11):695-9. DOI: 10.1056/NEJM199409153311102. View

DESMONTS G, Couvreur J . Toxoplasmosis in pregnancy and its transmission to the fetus. Bull N Y Acad Med. 1974; 50(2):146-59. PMC: 1749349. View

Jeannel D, Costagliola D, Niel G, Hubert B, Danis M . What is known about the prevention of congenital toxoplasmosis?. Lancet. 1990; 336(8711):359-61. DOI: 10.1016/0140-6736(90)91890-m. View

Peyron F, Wallon M, Bernardoux C . Long-term follow-up of patients with congenital ocular toxoplasmosis. N Engl J Med. 1996; 334(15):993-4. DOI: 10.1056/NEJM199604113341517. View

10.

Wallon M, Gandilhon F, Peyron F, Mojon M . Toxoplasmosis in pregnancy. Lancet. 1994; 344(8921):541. View

11.

Knerer B, Hayde M, Gratzl R, Strobl W, Pollak A, Gratz G . [Direct detection of Toxoplasma gondii with polymerase chain reaction in diagnosis of fetal toxoplasma infection]. Wien Klin Wochenschr. 1995; 107(4):137-40. View

12.

Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, Macaleese J . Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr. 1989; 115(5 Pt 1):765-9. DOI: 10.1016/s0022-3476(89)80660-2. View

13.

Roux C, Desmont G, Mulliez N, GAULIER M, Tufferaud G, Marmor D . [Toxoplasmosis and pregnancy. Evaluation of 2 years of prevention of congenital toxoplasmosis in the maternity ward of Hôpital Saint-Antoine (1973-1974)]. J Gynecol Obstet Biol Reprod (Paris). 1976; 5(2):249-64. View

14.

Douche C, Benabdesselam A, Mokhtari F, Le Mer Y . [Value of prevention of congenital toxoplasmosis]. J Fr Ophtalmol. 1996; 19(5):330-4. View

15.

Eskild A, Oxman A, Magnus P, Bjorndal A, Bakketeig L . Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?. J Med Screen. 1996; 3(4):188-94. DOI: 10.1177/096914139600300406. View

16.

Porter S, Sande M . Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992; 327(23):1643-8. DOI: 10.1056/NEJM199212033272306. View

17.

Berrebi A, Kobuch W, Bessieres M, Bloom M, Rolland M, Sarramon M . Termination of pregnancy for maternal toxoplasmosis. Lancet. 1994; 344(8914):36-9. DOI: 10.1016/s0140-6736(94)91054-5. View

18.

SHEFFIELD H, MELTON M . Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures. J Parasitol. 1975; 61(4):704-12. View

19.

Henri T, Jacques S, Rene L . Twenty-two years screening for toxoplasmosis in pregnancy: Liege-Belgium. Scand J Infect Dis Suppl. 1992; 84:84-5. View